BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Bioptigen Device Receives Canadian Regulatory Clearance


2/28/2012 8:39:34 AM

Triangle Business Journal by Lauren K. Ohnesorge, Staff Writer

Durham-based Bioptigen Inc. has received a medical device license from Health Canada to begin marketing its hand-held Envisu SDOIS C2200 and C2300 ophthalmic imaging systems for patient use in Canada.

Marketing in the United States is still pending FDA approval, but President and CEO Eric Buckland said the company is prepared to start selling and shipping to clinical users in Canada now. The handheld Envisu systems allow physicians to scan patients’ eyes without having to bring a patient to the scanner, which is particularly helpful when treating children.

Bioptigen employs 20 people locally and is moving forward with additional plans for new technology.




Bioptigen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->